Stelios Papadopoulos

(Dr. Stelios Papadopoulos Ph.D.)

Currently holds positions in Regulus Therapeutics Inc, Biogen Inc and Exelixis Inc

Positions

Position Company Period
Independent Chairman of the Board Regulus Therapeutics Inc June 11, 2013 -
Independent Chairman of the Board Biogen Inc June 1, 2014 -
Independent Chairman of the Board, Co-Founder Exelixis Inc Jan. 1, 1998 -
Independent Director Biogen Inc July 1, 2008 - June 1, 2014
Independent Director Regulus Therapeutics Inc Jan. 2, 2009 - June 11, 2013
Stelios Papadopoulos's trades of Exelixis Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-05-22 2024-05-20 S Sale
11,437 -0.9%
21.00
USD 240,177
11,437 -0.9% 21.00 USD 240,177
2022-02-24 2022-02-22 S Sale
84,515 -6.5%
19.56
USD 1,653,113
84,515 -6.5% 19.56 USD 1,653,113
2021-05-13 2021-05-11 S Sale
5,473 -0.4%
25.01
USD 136,880
5,473 -0.4% 25.01 USD 136,880
2021-05-13 2021-05-11 S Sale
5,075 -0.4%
25.00
USD 126,875
5,075 -0.4% 25.00 USD 126,875
2021-05-13 2021-05-11 S Sale
10,222 -0.8%
24.95
USD 255,039
10,222 -0.8% 24.95 USD 255,039
2020-05-08 2020-05-08 S Sale
45,000 -4.1%
25.84
USD 1,162,800
45,000 -4.1% 25.84 USD 1,162,800
2019-05-08 2019-05-07 B Purchase
370,370 +45.2%
1.08
USD 400,000
370,370 +45.2% 1.08 USD 400,000
2019-02-22 2019-02-21 S Sale
26,250 -2.5%
21.25
USD 557,813
26,250 -2.5% 21.25 USD 557,813
2019-01-02 2018-12-28 B Purchase
50,000 +6.4%
1.09
USD 54,570
50,000 +6.4% 1.09 USD 54,570
2018-12-28 2018-12-26 B Purchase
90,000 +13.5%
0.95
USD 85,878
90,000 +13.5% 0.95 USD 85,878
2017-07-25 2017-07-25 B Purchase
1,000,000 +129.8%
0.91
USD 910,000
1,000,000 +129.8% 0.91 USD 910,000
2017-03-23 2017-03-21 B Purchase
200,000 +99.7%
1.20
USD 239,800
200,000 +99.7% 1.20 USD 239,800
// ... existing code ... // ... rest of the file ...